Michael D. Bright - Concepedia

Author

Michael D. Bright

Institute of Cancer Research ORCID

Also Known As

Bright, Michael, Bright, Michael D., M D Bright, M. Bright, Michael Bright, Michael D. Bright

Publications

895

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research Imperial College London King's College London

About

Michael D. Bright is an author at Institute of Cancer Research specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	206
2	Cell Biology	5	5	182
3	Natural Sciences	3	3	112
4	Cellular Physiology	3	3	94
5	Biochemistry	1	1	24

Michael D. Bright

Publications

518

Citations

H-Index

Page 1

	Year	Citations
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control Charlotte Pawlyn, Michael D. Bright, Amy Buros, Blood Cancer Journal	2017	103
Achieving <i>In Vivo</i> Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders Benjamin R. Bellenie, Kwai-Ming J. Cheung, Ana Varela, Journal of Medicinal Chemistry	2020	72
Cleavage of <i>BLOC1S1</i> mRNA by IRE1 Is Sequence Specific, Temporally Separate from <i>XBP1</i> Splicing, and Dispensable for Cell Viability under Acute Endoplasmic Reticulum Stress Michael D. Bright, Daniel N. Itzhak, Christopher P. Wardell, Molecular and Cellular Biology Acute Er StressTranscriptional RegulationSignal TransductionCell RegulationMolecular Regulation	2015	66
HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target Jacqueline H. L. Fok, Somaieh Hedayat, Lei Zhang, Clinical Cancer Research	2018	56
The motor protein myosin 1G functions in FcγR-mediated phagocytosis Anna Dart, Sylvain Tollis, Michael D. Bright, Journal of Cell Science Unconventional Class-i MyosinCup ClosureImmunologyCytoskeletonCellular Physiology	2012	45
PAK1 and PAK2 have different roles in HGF-induced morphological responses Michael D. Bright, Andrew P. Garner, Anne J. Ridley Cellular Signalling Developmental BiologySignal TransductionHgf-induced Morphological ResponsesSignaling PathwayReceptor Tyrosine Kinase	2009	38
An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration Virginia Tajadura‐Ortega, Ritu Garg, Richard Allen, BMC Biology	2018	32
Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors Owen A. Davis, Kwai-Ming J. Cheung, Alfie Brennan, Journal of Medicinal Chemistry Combinatorial ChemistryDrug TargetMolecular BiologyBtb DomainChemical Biology	2022	24
Oncogenic RAC1 and NRAS drive resistance to endoplasmic reticulum stress through MEK/ERK signalling Michael D. Bright, Paul A. Clarke, Paul Workman, Cellular Signalling Sirna ScreeningApoptosisMolecular BiologyCell DeathCancer Biology	2018	22
Multiple autophosphorylations significantly enhance the endoribonuclease activity of human inositol requiring enzyme 1α Daniel N. Itzhak, Michael D. Bright, Amin Mirza, BMC Biochemistry	2014	20

Page 1